VideoHIVViral Hepatitis and Liver DiseaseAPACC 2018Social media platforms for LGBT inclusion | Laurindo GarciaView Video
VideoHIVViral Hepatitis and Liver DiseaseAPACC 2018Systematic review of social media HIV interventions | Bolin Cao, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseAPACC 2018Public health approach to reduce the burden of advanced HIV disease | Polin Chan, MDView Video
LLLinghua LiMD, PhDVideoHIVViral Hepatitis and Liver DiseaseAPACC 2018Challenges in the management of advanced HIV disease from the clinical perspective | Linghua Li, MD, PhDView Video
NKNagalingeswaran KumarasamyMD, FRCP, PhDVideoHIVViral Hepatitis and Liver DiseaseAPACC 2018Current gaps between policy and practice in the Asia Pacific region | Nagalingeswaran Kumarasamy, MDView Video
VideoHIVViral Hepatitis and Liver DiseaseAPACC 2018IP and regulatory barriers to access ART and drugs for co-infections in LMICs | Leena MenghaneyView Video
VideoHIVViral Hepatitis and Liver DiseaseAPACC 2018WHO’s regional strategies | Polin Chan, MDView Video
NPNittaya PhanuphakMD, PhDVideoHIVViral Hepatitis and Liver DiseaseAPACC 2018David Cooper Memorial Lecture: Current effort to control the epidemic in the region | Nittaya Phanuphak, MD, PhDView Video
AWAnnemarie WensingMD, PhDVideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018Prospects for cure | Annemarie Wensing, MD, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018What is the place of the monoclonal antibodies in the clinic | Julià Blanco, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018Reduced drug regimens | Andrea De Luca, MDView Video
VideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018What’s in the pipeline? Presentations by scientists from the industry | Jean-Marc Steens, MDView Video
